J-shaped association between plasma glucose concentration and cardiovascular disease mortality over a follow-up of 32years

Preventive Medicine

Volumn 57, Issue 5, 2013, Pages 623-628

  von Gunten, Elisabeth ^a   Braun, Julia ^b   Bopp, Matthias ^b   Keller, Ulrich ^c   Faeh, David ^b  

^a University of Zurich ^*

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cardiovascular risk factors; Diabetes mellitus; Follow up; Glucose; Lifestyle; Mortality; Switzerland

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SURVIVAL; SWITZERLAND;

CARDIOVASCULAR RISK FACTORS; DIABETES MELLITUS; FOLLOW-UP; GLUCOSE; LIFESTYLE; MORTALITY; SWITZERLAND;

ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEALTH PROMOTION; HEALTH SURVEYS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; SEX FACTORS; SWITZERLAND;

EID: 84885841863     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.08.016     Document Type: Article

References (41)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62-S69.
2. Athyros V.G., Hatzitolios A.I., Karagiannis A., et al. IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis. Arch. Med. Sci. 2011, 7:984-992.
3. Balkau B., Shipley M., Jarrett R.J., et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998, 21:360-367.
4. Balkau B., Bertrais S., Ducimetiere P., Eschwege E. Is there a glycemic threshold for mortality risk?. Diabetes Care 1999, 22:696-699.
5. Balkau B., Hu G., Qiao Q., Tuomilehto J., Borch-Johnsen K., Pyorala K. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia 2004, 47:2118-2128.
6. Barr E.L., Zimmet P.Z., Welborn T.A., et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007, 116:151-157.
7. Batty G.D., Kivimaki M., Davey Smith G., Marmot M.G., Shipley M.J. Post-challenge blood glucose concentration and stroke mortality rates in non-diabetic men in London: 38-year follow-up of the original Whitehall prospective cohort study. Diabetologia 2008, 51:1123-1126.
8. Berrut S., Junker C., Schweiz Bundesamt für Statistik Von Generation zu Generation Entwicklung der Todesursachen 1970 bis 2004 2008, Office fédéral de la statistique OFS, Neuchâtel.
9. Bopp M., Spoerri A., Zwahlen M., et al. Cohort profile: the Swiss National Cohort-a longitudinal study of 6.8million people. Int. J. Epidemiol. 2009, 38:379-384.
10. Bopp M., Braun J., Faeh D., Gutzwiller F. Establishing a follow-up of the Swiss MONICA participants (1984-1993): record linkage with census and mortality data. BMC Publ. Health 2010, 10:562.
11. Bopp M., Zellweger U., Faeh D. Routine data sources challenge international diabetes Federation extrapolations of national diabetes prevalence in Switzerland. Diabetes Care 2011, 34:2387-2389.
12. Bopp M., Braun J., Gutzwiller F., Faeh D. Health risk or resource? Gradual and independent association between self-rated health and mortality persists over 30years. PLoS One 2012, 7:e30795.
13. Brunner E.J., Shipley M.J., Witte D.R., Fuller J.H., Marmot M.G. Relation between blood glucose and coronary mortality over 33years in the Whitehall study. Diabetes Care 2006, 29:26-31.
14. Danaei G., Lawes C.M., Vander Hoorn S., Murray C.J., Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 2006, 368:1651-1659.
15. Danaei G., Finucane M.M., Lu Y., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370country-years and 2.7million participants. Lancet 2011, 378:31-40.
16. DECODE Study Group Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?. Diabetes Care 2003, 26:688-696.
17. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):S5-S20.
18. Faeh D., Braun J., Tarnutzer S., Bopp M. Obesity but not overweight is associated with increased mortality risk. Eur. J. Epidemiol. 2011, 26:647-655.
19. Faeh D., Rohrmann S., Braun J. Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts. Eur. J. Epidemiol. 2013, 28:551-555.
20. Finucane M.M., Stevens G.A., Cowan M.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
21. Gutzwiller F., Nater B., Martin J. Community-based primary prevention of cardiovascular disease in Switzerland: methods and results of the National Research Program (NRP 1A). Prev. Med. 1985, 14:482-491.
22. Huang P.L. A comprehensive definition for metabolic syndrome. Dis. Model. Mech. 2009, 2:231-237.
23. Levitan E.B., Song Y., Ford E.S., Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch. Intern. Med. 2004, 164:2147-2155.
24. Levitzky Y.S., Pencina M.J., D'Agostino R.B., et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J. Am. Coll. Cardiol. 2008, 51:264-270.
25. Lloyd-Jones D.M., Martin D.O., Larson M.G., Levy D. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann. Intern. Med. 1998, 129:1020-1026.
26. Malyszko J., Banach M. Prediabetes, prehypertension - do we need pre-ckd?. Curr. Vasc. Pharmacol. 2013, (Apr 25. [Epub ahead of print]).
27. OECD Health at a Glance 2011: OECD Indicators 2011, OECD Publishing, (http://dx.doi.org/10.1787/health_glance-2011-en. Accessed 2013-04-18).
28. Preis S.R., Hwang S.J., Coady S., et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009, 119:1728-1735.
29. Preiss D., Welsh P., Murray H.M., et al. Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. Eur. Heart J. 2010, 31:1230-1236.
30. Sarwar N., Gao P., Seshasai S.R., et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222.
31. Seshasai S.R., Kaptoge S., Thompson A., et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 2011, 364:829-841.
32. Sorkin J.D., Muller D.C., Fleg J.L., Andres R. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 2005, 28:2626-2632.
33. Swiss Federal Statistical Office Swiss cause of death statistics (Accessed 2013-04-18). http://www.bfs.admin.ch/bfs/portal/en/index/infothek/erhebungen__quellen/blank/blank/cod/02.html%5D.
34. Wandell P.E., Theobald H. The association between blood glucose value and long-term mortality. Diabetes Metab. 2005, 31:588-594.
35. Wandell P.E., Theobald H. The association between low fasting blood glucose value and mortality. Curr. Diabetes Rev. 2007, 3:274-279.
36. Wang H., Dwyer-Lindgren L., Lofgren K.T., et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013, 380:2071-2094.
37. Wei M., Gibbons L.W., Mitchell T.L., Kampert J.B., Stern M.P., Blair S.N. Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation 2000, 101:2047-2052.
38. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011, 94:311-321.
39. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
40. World Health Organization Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation 2006, World Health Organization, Geneva, Switzerland.
41. World Health Organization International Classification of Diseases (ICD) (Accessed 2013-04-18). http://www.who.int/classifications/icd/en.